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Sequencing studies have provided a comprehensive catalogue of the expression of  
intergenic long non-coding RNAs (lincRNAs) in 13 human T- and B-cells subtypes. A 
fraction of these lincRNAs are shown to be subtype selective and evidence is presented 
that linc-MAF-4 might regulate T-cell differentiation  
 
 
 
 
 
 
 
 
 
It is now widely accepted that the microRNA family of short non-coding RNAs play an 
important regulatory role in virtually all aspects of the immune response including the 
proliferation, differentiation and activation of immune cells 1. In contrast, little is known 
about long non-coding RNAs (lncRNAs), tens of thousands of which have been identified 
using high throughput sequencing. To address this issue, the report by Ranzani et al 
(REF) has catalogued the expression of the intergenic family of lncRNAs (lincRNA) in 13 
human T- and B- subtypes, from which they have identified a group of 180 lincRNAs that 
are subtype selective. Significantly, a member of this group entitled linc-MAF-4 was 
shown to promote a CD4+ TH1 phenotype by acting in cis to suppress the expression of 
the CD4+ TH2 promoting transcription factor, MAF-4.  
 
Interest in this area of non-coding RNAs has been driven by the rapid advances in 
sequencing technology, which have shown that much of the genome is transcribed into 
lncRNAs (> 200 nucleotides) 2. Since little is currently known about their function and 
mechanism, these tend to be arbitrarily grouped into intergenic, antisense and 
pseudogenes families, based upon their position relative to protein coding genes and/or 
sequence conservation. In this regard, the lincRNAs that are described by Ranzani et al. 
(REF) are located between protein-coding genes. These differ from the antisense 
lncRNAs that are transcribed across the exons of protein coding genes from the opposite 
strand and the transcribed pseudogenes lncRNAs that are generally produced when a 
gene losses its ability to produce a functional protein.   
 
The first indication that lncRNAs might regulate the innate immune response was the 
identification of a lincRNA located downstream of Cox2 (PTGS2), that was up-regulated 
in mouse macrophages following exposure to lipopolysaccharide 3. As a result of its 
proximity to the Cox2 gene, this was named lincRNA-Cox2. Subsequent studies have 
shown that lincRNA-Cox2, as well as other lncRNAs such as LETHE, THRIL, NEAT1, 
PACER and IL-1-RBT46 regulate the production of inflammatory mediators although 
their physiological importance has yet to be confirmed using an in vivo model of innate 
immunity 4,5.   
 
By comparison, despite the fact that the T-cell associated lncRNAs, NRON (non-coding 
repressor of NFAT) and Gas5 (growth arrest specific 5) were discovered nearly a decade 
ago, much less is known about the adaptive immune response 4,5. Crucially, this situation 
that has been transformed by the publication of Hu et al 6 and the current report by 
Ranzani et al. (REF), that are primarily based upon sequencing studies. However, before 
proceeding with a detailed discussion on the these papers, it is also important to highlight 
the genetic studies of Gomez et al 7, which are the first to have demonstrated that 
lincRNAs regulated the immune response in vivo. Thus, this seminal piece of work 
begins with the identification of a lincRNA named NeST (Nettoie Salmonella pas 
Theilers’s) within a genetic locus (Tmevp3) that was historically associated with murine 
viral susceptibility 7. The authors then proceed to show that over-expression of NeST was 
responsible for the increased Theilers’s viral persistence and reduced Salmonella 
enterica pathogenesis observed in mice, that was mediated through NeST induced up-
regulation of IFN in CD8+ T-cells 7.  
 
As already mentioned, investigations into lncRNAs commonly begin by using sequencing 
to identify those that are differentially expressed in different biological conditions. It is this 
approach that has been employed by Ranzani et al. (REF) to examine the profile of 
lincRNA expression in 13 lymphocytes populations including 7 CD4+ T-cells subsets, 3 
CD8+ T-cell subsets and 3 B-cell subsets. Significantly, a similar approach was adopted 
to investigate the role of lincRNAs during T-cell development and differentiation, in an 
article by Hu et al 6 previously published in Nature Immunology. However, in contrast to 
the current report that isolated lymphocytes from human blood, Hu et al 6 employed 
mouse T-cells derived from the spleen (proliferation) or following differentiation of naïve 
CD4+ cells in vitro. The distinction between using human and mouse cells is crucial since 
lincRNAs are generally believed to exhibit low evolutionary sequence conservation, with 
estimates that only ~ 15% of mouse protein-coding genes have homologs in humans 8. It 
is therefore difficult to extrapolate profiling studies between these two species and 
underlies the primary impact of the current publication.   
 
In order to catalogue the lincRNAs, the authors employed a combination of programmes 
to alignment (Tophat and STAR) and assemble (Cufflinks and Trinity) the sequence data. 
Following the removal of potential protein coding genes, Ranzani et al. (REF) identified 
4754 lincRNAs including 563 novel transcripts, within the various human lymphocytes 
populations, a number comparable with the 1524 lincRNAs identified in mouse T-cells 6. 
Unfortunately, no attempt was made to compare the sequences of these two populations 
although both were located close to, and their expression correlated with, genes 
implicated in the immune response, implying a possible functional link. Having identified 
these lymphocyte association lincRNAs, cluster analysis showed that in comparison to 
mRNAs, these lincRNAs are expressed in a highly subtype specific manner, an 
observation that was previously made in mouse T-cells 6. Importantly, this included a 
smaller group of 180 lincRNAs that were selectively expressed in a single T- or B-cell 
population (> 2.5 fold increase compared to all other populations) (Figure).  
 
Clearly, the selective expression of lincRNAs in different lymphocytes populations raised 
the question of whether or not they are regulating lymphocyte differentiation and/or 
function. To address this, the authors examined the role of linc-MAF-4, a lincRNA that 
was selectively expressed in CD4+ TH1 cells and, as the name implies, was located 
upstream of MAF. This location is important since MAF-4 has been implicated in the 
differentiation of CD4+ TH2 and the authors found an inverse correlation between the 
expression of linc-MAF-4 and MAF-4. Significantly, knockdown of linc-MAF-4 skewed the 
mRNA expression towards the CD4+ TH2 phenotype indicating that this might contribute 
to the establishment of the TH1 phenotype. Equivalent observations were made by Hu et 
al. 6 when examining lincR-Ccr2-5’AS, a lincRNA located adjacent to a cluster of 
chemokine receptor-encoding genes including Ccr2. This was selectively up-regulated 
during differentiation of CD4+ TH2 cells and knockdown studies demonstrated that lincR-
Ccr2-5’AS was not only required for T-cell migration into the lung but also appeared to 
regulate many genes associated with T-cell differentiation 6.  
 
Having demonstrated repression of MAF-4 expression, Ranzani et al. (REF) then 
proceeded to investigate the mechanism of action of linc-MAF-4. To our mind, this is one 
of the most interesting aspects of the emerging lncRNA field, with evidence that the 
actions of individual lncRNAs are mediated both through protein binding and/or base 
pairing with RNA/DNA 9. Indeed, with the increasing numbers of immune-related 
lncRNAs that have been characterized, it is possible to divide these into 3 general 
mechanisms. The first can act as ‘decoys’ to prevent protein-DNA interaction and include 
those that bind to nuclear factor-κB and the glucocorticoid receptor 4,5. Another group has 
been shown to bind to proteins such as the importin-beta family and signal transducer 
and activator of transcription 3, and antagonize their interaction with other proteins 4,5. In 
contrast to these, less is known about the final group that interact with components of 
chromatin modifying complexes including the polycomb repressor complex 2 (PRC2) 4,5. 
Interestingly, it would appear that linc-MAF-4 falls within this final group since its action 
required DNA looping to bring linc-MAF-4 into proximity with the MAF-4 promoter, and 
the subsequent recruitment and activation of the PRC2 associated histone 
methytransferases, EZH2. The histone demethylase LSD1 was also located in the 
complex although its activity appeared unchanged. As with all these chromatin-
associated lncRNAs, additional studies are required to determine all the component of 
the chromatin complex, the kinetics of assembly and contribution of linc-MAF-4.  
 
Overall, the report by Ranzani et al. (REF) has provided the first comprehensive 
catalogue of lincRNA expression in the various human T- and B-cells populations of 
circulating blood. As with linc-MAF-4, it is to be hoped that this will provide the 
foundations for the difficult and time-consuming process of identification of those 
lincRNAs that regulate the various aspects of the adaptive immune response. However, 
in moving forward there are a number of issues that will need to be addressed. As 
already emphasized, potentially the most significant hurdle is the lack of evolutionary 
sequence conservation, which makes it difficult to extrapolate from animal models to 
humans. This will need to be addressed through the development of more appropriate 
algorithms for the identification of the protein binding structures and/or the short 
RNA/DNA pairing regions that are implicated in lncRNA action 8. It will also be important 
to develop more efficient and high-throughput approaches to the identification of the 
functional lncRNAs amongst the thousands that are characteristically uncovered using 
high-throughput sequencing. In this regard, transcriptional regulation using CRISP 
interference (CRISPi) and over-expression (CRISPa) appears like an exciting alternative 
to using siRNA and antisense 10 and has already been employed to knockdown six 
common lncRNAs 11. In summary, we are only at the beginning of our journey into 
understanding the role of the lincRNAs and the other families of lncRNAs, in the immune 
response. However, if this turns out to be as varied as that of miRNAs, there will be many 
exciting discoveries ahead. 
  
 
 
 
Figure Legend 
 
The illustration shows those human lymphocytes T- and B-cells subsets for which the 
profile of expression of long intergenic non-coding RNAs was determined and 
summarizes the potential interaction between linc-MAF-4 and MAF-4 in the regulation of 
the TH1 and TH2 phenotype. The number in brackets describes how many lincRNAs were 
selective expressed in each subset, the names and genomic positions being available in 
Figure 2 and the Supplemental Figure 2 of the manuscript by Ranzani et al. (REF).  
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